Members of the ARF family, including ARF-like (ARL) proteins, are associated with the development and progression of many types of cancer, including hepatocellular carcinoma [10, 11], renal cell carcinoma [12], colorectal cancer [13–17], lung cancer [14, 18], and breast cancer [13]. Here, CDKN2A is linked to lung cancer.